CONCENTRATIONS (Details Narrative) |
3 Months Ended | 6 Months Ended | 12 Months Ended | ||
---|---|---|---|---|---|
Jun. 30, 2019 |
Jun. 30, 2018 |
Jun. 30, 2019 |
Jun. 30, 2018 |
Dec. 31, 2018 |
|
Revenue [Member] | |||||
Percentage revenue from sale of unsecured Avaya claim | 32.00% | ||||
Licensees Four [Member] | |||||
Royalty receivables percentage | 80.00% | ||||
Licensees Four [Member] | Revenue [Member] | |||||
Concentration risk, percentage | 10.00% | 11.00% | |||
Licensees Three [Member] | |||||
Royalty receivables percentage | 82.00% | ||||
Licensees Three [Member] | Revenue [Member] | |||||
Concentration risk, percentage | 10.00% | 12.00% | 11.00% | ||
Licensees One [Member] | Revenue [Member] | |||||
Concentration risk, percentage | 56.00% | 41.00% | 43.00% | 64.00% | |
Licensees Two[Member] | Revenue [Member] | |||||
Concentration risk, percentage | 10.00% | 18.00% | 14.00% |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|